Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its paperwork for a U.S. initial public offering (IPO) filing on Tuesday.
Kidney disease drugmaker Maze files for IPO
Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised about $500 million privately, has a drug in Phase 2 testing.
Maze Opens 2025 IPO Class to Advance Kidney Disease Programs
Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in funding to support the development of its kidney disease pipeline.
Maze Therapeutics looks for IPO lodestar to guide kidney disease assets through clinical trials
Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to boost its kidney disease candidates further by going public. | Just a month after announcing a $115 million series D to advance its lead assets,
Maze Therapeutics Files for IPO
Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it would offer or give an anticipated price range. It plans to list shares on Nasdaq under the ticker MAZE.
World's largest ice maze opens with Guinness World Record certification
During a ceremony on Friday at TCO Stadium, the festival's 18,148.89-square-foot ice maze with eight-foot-tall walls was ...
Minnesota is home to the largest ice maze ever built
The Minnesota Ice Festival broke the Guinness World Records for the largest ice maze.
GSL roundup: Karson Maze scores 19 to lead Mead Boys past Lewis and Clark; Brynn McGaughy propels Central Valley Girls over Shadle
Ridgeline 67, Mt. Spokane 30: Madi Crowley scored 23 points and the Falcons (9-2, 1-0) beat the visiting Wildcats (5-7, 0-1).